In this video, the authors describe their experience using a percutaneous left ventricular assist device (LVAD) as a bridge to transplant in a morbidly obese pediatric patient with severe heart failure due to viral myocarditis.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Mechanical Circulatory Assistance
Novel Application of a Percutaneous Left Ventricular Assist Device as a Bridge to Transplant in a Pediatric Patient with Severe Heart Failure Due to Viral Myocarditis
June 30, 2015
Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis
June 20, 2015
The University of Wisconsin group analyzed the etiology, costs, and effect on survival of unplanned readmissions after LVAD surgery. At a median follow-up of 11 months, 68 of the 103 patients (66%) were readmitted. The top 3 causes of readmission were GI bleeding, driveline infection, and stroke.
Extracorporeal Membrane Oxygenation Support in Postcardiotomy Elderly Patients: The Mayo Clinic Experience
April 19, 2015
The Mayo Clinic reviewed its series using VA ECMO for postcardiotomy support in patients older than the age of 70 years. Not surprisingly, only a quarter of patients were able to be discharged alive.
April 19, 2015
The authors retrospectively analyzed the causes of death and their temporal relationship to surgery for close to 500 patients undergoing LVAD implantation at their institutions.
April 14, 2015
Filmed at the 2015 STS Annual Meeting in San Diego, Michael Bolanos and Mark Slaughter discuss topics in mechanical circulatory support and heart transplantation.
2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care
April 9, 2015
This concensus statement reviews the unique physiology, insertion techniques, and clinical indications for use of percutaneous mechanical circulatory support devices. As the options for management of different etiologies of heart failure in adult and pediatric populations expand, understanding the advantages of specific devices is vital.
Extracorporeal life support in cardiogenic shock: impact of acute versus chronic etiology on outcome
March 2, 2015
The authors retrospectively analyze outcomes for patients placed on ECMO for cardiogenic shock, and separately analyze the patients depending on whether the ECMO support was for isolated acute cardiogenic shock or for acute-upon-chronic cardiogenic shock.
February 6, 2015
The Columbia University group performed this retrospective review of femoral VA ECMO at their institution from 2007-2013, and analyzed short-term outcomes based on the size of the arterial cannula.
February 5, 2015
Extracorporeal membrane oxygenation (EMCO) offers a therapeutic option for moribund patients of all ages with acute pumonary or cardiac failure. The authors present a retrospective analysis of the largest single institution experience with ECMO support, and present their perspective on the evolving use of ECMO supported by four decades of clinical r
January 25, 2015
This study from the University of Texas Southwestern sought to analyze the effects of mechanical unloading during prolonged LVAD support on mitochondrial mass, DNA damage response (DDR), and cardiomyocyte proliferation. Ten matched human samples of LV myocardium were analyzed before and after mechanical circulatory support.